Meplazumab
Meplazumab is a human IgG1 monoclonal antibody (mAb) targeting Basigin/CD147. Meplazumab can be used in COVID-19 pneumonia, Coronary artery disease and Malaria research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
Product Name Alternative
HcHAb18
UNSPSC
12352203
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Purity
99.25
Smiles
[Meplazumab]
References & Citations
[1]Bian H, et al. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial. Signal Transduct Target Ther. 2021 May 17;6 (1) :194.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx312531-01 20 µg
Myotubularin Related Protein 6 (MTMR6) Antibody (FITC)
Sign In for Pricing
View Details 
abx312531-02 50 µg
Myotubularin Related Protein 6 (MTMR6) Antibody (FITC)
Sign In for Pricing
View Details 
abx312531-03 100 µg
Myotubularin Related Protein 6 (MTMR6) Antibody (FITC)
Sign In for Pricing
View Details abx312531-04 200 µg
Myotubularin Related Protein 6 (MTMR6) Antibody (FITC)
Sign In for Pricing
View Details abx312531-05 1 mg
Myotubularin Related Protein 6 (MTMR6) Antibody (FITC)
Sign In for Pricing
View Details